Generic drug makers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns about how much of a suspected carcinogen was turning up in them. According to one of them, the financial hit for the recall was not insignificant.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,